Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11 Pt 1
|
pubmed:dateCreated |
1977-4-30
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-5038
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
339-44
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:190137-Antigens, Viral,
pubmed-meshheading:190137-Binding Sites, Antibody,
pubmed-meshheading:190137-Cell Line,
pubmed-meshheading:190137-Herpesvirus 4, Human,
pubmed-meshheading:190137-Immunoglobulin G,
pubmed-meshheading:190137-Immunosorbents,
pubmed-meshheading:190137-Iodine Radioisotopes,
pubmed-meshheading:190137-Solubility
|
pubmed:year |
1975
|
pubmed:articleTitle |
Studies on the Epstein-Barr virus (EBV)-associated early antigen (EA) with 125 I-labelled IgG.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|